India’s drug pricing authority has brought two key anti-diabetic drugs – Sitagliptin-Metformin combination and Linagliptin-Metformin combination – under price control. For a 2.5 mg Linagliptin-metformin tablet, the price has been fixed at 16.17, and for the same combination in 5 mg strength, the price will be 25.33 per tablet.
